Determination of urinary 8-epi-prostaglandin F2α using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roberts, 1997, The generation and actions of isoprostanes, Biochim Biophys Acta, 1345, 121, 10.1016/S0005-2760(96)00162-2
Carpenter, 1998, Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS, Chest, 114, 1653, 10.1378/chest.114.6.1653
Pratico, 1998, Increased F2-isoprostanes in Alzheimer’s disease, FASEB J, 12, 1777, 10.1096/fasebj.12.15.1777
Hill, 1999, Increased urinary F2-isoprostane excretion in alcoholic liver disease, Free Radic Biol Med, 26, 656, 10.1016/S0891-5849(98)00250-0
Bachi, 1996, Measurement of urinary 8-epi-prostaglandin F2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers, Free Radic Biol Med, 20, 619, 10.1016/0891-5849(95)02087-X
Mori, 1999, An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry, Anal Biochem, 268, 117, 10.1006/abio.1998.3037
Proudfoot, 1999, Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation—a comparison of enzyme immunoassay with gas chromatography/mass spectrometry, Anal Biochem, 272, 209, 10.1006/abio.1999.4187
Niessen, 1998, Advances in instrumentation in liquid chromatography-mass spectrometry and related liquid-introduction techniques, J Chromatogr A, 794, 407, 10.1016/S0021-9673(97)01112-6
Maurer, 1998, Liquid chromatography-mass spectrometry in forensic and clinical toxicology, J Chromatogr B Biomed Sci Appl, 713, 3, 10.1016/S0378-4347(97)00514-8
Mizugaki, 1999, Determination of leukotriene E4 in human urine using liquid chromatography-tandem mass spectrometry, J Chromatogr B, 729, 279, 10.1016/S0378-4347(99)00174-7
Wentzel, 1999, Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment, Diabetes, 48, 813, 10.2337/diabetes.48.4.813
Natarajan, 1996, Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors, Am J Physiol, 271, H159
Michoud, 1998, In vivo effect of 8-epi-PGF2α on retinal circulation in diabetic and non-diabetic rats, Prostaglandins Leukot Essent Fatty Acids, 59, 349, 10.1016/S0952-3278(98)90095-3
Palmer, 1998, Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function of small mesenteric arteries of the streptozotocin-diabetic rat, Diabetologia, 41, 148, 10.1007/s001250050883
Gopaul, 1995, Plasma 8-epi-PGF2α levels are elevated in individuals with non-insulin dependent diabetes mellitus, FEBS Lett, 368, 225, 10.1016/0014-5793(95)00649-T
Davi, 1999, In vivo formation of 8-iso-prostaglandin F2α and platelet activation in diabetes mellitus, Circulation, 99, 224, 10.1161/01.CIR.99.2.224
Morrow, 1995, Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage, N Engl J Med, 332, 1198, 10.1056/NEJM199505043321804
Hishinuma, 1996, Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring, Prostaglandins Leukot Essent Fatty Acids, 54, 445, 10.1016/S0952-3278(96)90029-0
Hishinuma, 1998, Elevation of the thromboxane A2/prostacyclin ratio in urine of diabetic mice analyzed by gas chromatography/selected ion monitoring, Prostaglandins & other Lipid Mediators, 55, 83, 10.1016/S0090-6980(98)00012-4
Hishinuma, 1999, Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic, Prostaglandins & other Lipid Mediators, 58, 263, 10.1016/S0090-6980(99)00029-5
Morrow, 1990, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc Natl Acad Sci USA, 87, 9383, 10.1073/pnas.87.23.9383
Banerjee, 1992, Effects of a never prostaglandin, 8-epi-PGF2α, in rabbit lung in situ, Am J Physiol, 263, H660
Takahashi, 1992, Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2α, in the rat. Evidence for interaction with thromboxane A2 receptors, J Clin Invest, 90, 136, 10.1172/JCI115826
Morrow, 1994, Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes, J Biol Chem, 269, 4317, 10.1016/S0021-9258(17)41781-9
Pratico, 1996, Local amplification of platelet function by 8-epi prostaglandin F2α is not mediated by thromboxane receptor isoforms, J Biol Chem, 271, 14916, 10.1074/jbc.271.25.14916
Fukunaga, 1995, Stimulatory effect of 8-Epi-PGF2α, an F2-isoprostane, on endothelin-1 release, J Cardiovasc Pharmacol, 26, S51, 10.1097/00005344-199526003-00016
Yura, 1995, Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2, Adv Prostaglandin Thromboxane Leukot Res, 23, 237